Article
Key role of soluble epoxide hydrolase in the neurodevelopmental disorders of offspring after maternal immune activation
19 Mar 2019
Abstract excerpt
mRNA in postmortem brain samples (Brodmann area 9 and 40) from ASD patients was higher than that of controls. Treatment with 1-trifluoromethoxyphenyl-3-(1-propionylpiperidin-4-yl)urea (TPPU), a potent sEH inhibitor, in juvenile offspring from prenatal day (P) 28 to P56 could prevent cognitive deficits and loss of parvalbumin (PV) immunoreactivity in the medial PFC of adult offspring after MIA. In addition, dosing...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
